v3.25.4
Consolidated Statements of Shareholders' Deficit - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Beginning balance (in shares) at Dec. 31, 2022   22,014,000    
Beginning balance at Dec. 31, 2022 $ (438,177) $ 220 $ 5,182 $ (443,579)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss (15,287)     (15,287)
Exercise of common stock options (in shares)   20,000    
Exercise of common stock options 428 $ 0 428  
Stock-based compensation (in shares)   335,000    
Stock-based compensation 14,855 $ 3 14,852  
Repurchases of common stock (in shares)   (134,000)    
Repurchases of common stock (3,747) $ (1) (3,746) 0
Ending balance (in shares) at Dec. 30, 2023   22,235,000    
Ending balance at Dec. 30, 2023 (441,928) $ 222 16,716 (458,866)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (20,334)     (20,334)
Exercise of common stock options (in shares) 0      
Stock-based compensation (in shares)   209,000    
Stock-based compensation $ 11,444 $ 3 11,441  
Repurchases of common stock (in shares)   (56,000)    
Repurchases of common stock $ (768) $ (1) (767) 0
Ending balance (in shares) at Dec. 28, 2024 22,388,000 22,388,000    
Ending balance at Dec. 28, 2024 $ (451,586) $ 224 27,390 (479,200)
Increase (Decrease) in Stockholders' Equity [Roll Forward]        
Net loss $ (131,958)     (131,958)
Exercise of common stock options (in shares) 0      
Stock-based compensation (in shares)   628,000    
Stock-based compensation $ 6,282 $ 6 6,276  
Repurchases of common stock (in shares)   (156,000)    
Repurchases of common stock $ (1,213) $ (1) (1,212)  
Ending balance (in shares) at Jan. 03, 2026 22,860,000 22,860,000    
Ending balance at Jan. 03, 2026 $ (578,475) $ 229 $ 32,454 $ (611,158)